Pricing Log in Create free account

Caribou Biosciences, Inc. (CRBU) vs iBio, Inc. (IBIO)

Caribou Biosciences, Inc. and iBio, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and iBio, Inc. are of similar size ($44.4M and $44.2M). Caribou Biosciences, Inc. grew revenue faster over the last twelve months: 1.60% against −66.6%. iBio, Inc. has the higher net margin (0.00% vs −1,085.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, iBio, Inc. leads on 11 and Caribou Biosciences, Inc. on 5.

Valuation

Metric CRBU IBIO Biotechnology median
P/E n/m n/m 10.60
P/S 5.01 115.62 9.40
P/B 0.62 0.91 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.45 0.25 0.66
EV/Sales (5.03) (12.78) 9.02
Earnings yield (234.09%) (45.33%) (32.88%)
Free cash flow yield (275.02%) (31.04%) (23.13%)

Profitability

Metric CRBU IBIO Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (1,140.55%) 0.00% 0.00%
Net margin (1,085.00%) 0.00% 0.00%
Free cash flow margin (985.95%) 0.00% 0.00%
Return on equity (93.80%) (65.70%) (51.96%)
Return on assets (64.44%) (54.04%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBU IBIO Biotechnology median
Revenue growth (TTM) 1.60% (66.55%) 6.76%
EPS growth (last fiscal year) 3.64% 81.71% 29.88%
Revenue growth, 5-year CAGR (2.03%) (42.83%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU IBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.97 7.85 4.97
Net debt to EBITDA 0.96 2.57 1.01

Dividend

Metric CRBU IBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBU IBIO Biotechnology median
Market cap 44.20m 44.43m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack